By Y. Peter Kang ( May 6, 2015, 8:02 PM EDT) -- Robbins Geller Rudman & Dowd LLP, lead counsel in a shareholder class action accusing Pfizer Inc. of misleading investors about the off-label marketing of various drugs, asked a New York federal judge on Wednesday to approve $94 million in attorneys' fees to be paid out of the $400 million settlement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.